-
NAO calls for cross-government initiative on childhood obesity
pharmatimes
September 23, 2020
A new report from the National Audit Office has concluded “it is not clear” that the Department of Health and Social Care’s (DHSC) current programme for reducing childhood obesity “will be able to make the step change needed in the timescale available”.
-
Gov unveils new anti-obesity measures
pharmatimes
July 28, 2020
The government has revealed a package of new measures falling under its new Obesity Strategy that are designed to improve health, ease the related burden on the NHS, and strengthen the public's resilience to COVID-19.
-
Obesity linked to higher risk of dementia
pharmatimes
June 30, 2020
New research suggests that weight management could play a significant role in reducing the risk of developing dementia, after finding that obesity is linked to a higher risk of the condition up to 15 years later.
-
Novo Nordisk's AM833 shows early success in obesity trials
pharmatimes
June 22, 2020
Novo Nordisk has unveiled headline results from two clinical trials with a novel once-weekly subcutaneous amylin analogue (AM833) - a Phase II monotherapy trial and a Phase I combination trial of AM833 and once-weekly subcutaneous semaglutide.
-
Newly discovered brain response to obesity drug may inform future treatments
worldpharmanews
March 05, 2020
The U.S. Food and Drug Administration-approved drug liraglutide has been shown to help obese patients lose weight by suppressing their appetite.
-
Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics
b3cnewswire
January 16, 2020
Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeutic antibodies announced that it has entered into an exclusive licence agreement with alytas therapeutics GmbH (alytas), for the development and ...
-
Obesity May Boost Effectiveness of a Lung Cancer Therapy
drugs
December 31, 2019
Obesity is seldom a friend to health, but in one medical context it might give patients a slight advantage, new research suggests.
-
Obesity May Up Cardiotoxicity Risk From Breast Cancer Therapy
drugs
December 25, 2019
Obesity is associated with an increased risk for cardiotoxicity among patients receiving treatment for breast cancer, according to a study published online in PLOS Medicine.
-
Could Obesity Alter a Child's Brain Structure?
drugs
December 25, 2019
Childhood obesity may be linked to changes in brain structure that might result in impulsive kids who struggle with problem-solving, a new study reports.
-
Age at Obesity Onset Tied to Risk for Type 2 Diabetes in Women
drugs
December 24, 2019
The age of onset of obesity and cumulative exposure to obesity are associated with the risk for type 2 diabetes, according to a study published online in Diabetologia.